April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Nico Gagelmann: Ide-cel versus cilta-cel for relapsed or refractory multiple myeloma
Jan 19, 2025, 22:11

Nico Gagelmann: Ide-cel versus cilta-cel for relapsed or refractory multiple myeloma

Nico Gagelmann, Chair of the CAR-T for plasma cell disorder committee at The EBMT, shared a post on X about a recent paper by him and colleagues published in HemaSphere:

“Finally published!

Ide-cel versus cilta-cel for relapsed or refractory multiple myeloma.”

“Idecabtagene vicleucel or ciltacabtagene autoleucel for relapsed or refractory multiple myeloma: An international multicenter study”

Authors: Maximilian Merz, Anca-Maria Albici, Bastian von Tresckow, Thomas Pabst, Nico Gagelmann et al.

Nico Gagelmann: Ide-cel versus cilta-cel for relapsed or refractory multiple myeloma

More posts featuring Nico Gagelmann.